Giovina Ruberti
Giovina Ruberti
Verified email at
TitleCited byYear
Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
C Giordano, G Stassi, R De Maria, M Todaro, P Richiusa, G Papoff, ...
Science 275 (5302), 960-963, 1997
Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing.
I Cascino, G Fiucci, G Papoff, G Ruberti
The Journal of Immunology 154 (6), 2706-2713, 1995
Multiple pathways originate at the Fas/APO‐1 (CD95) receptor: sequential involvement of phosphatidylcholine‐specific phospholipase C and acidic sphingomyelinase in the …
MG Cifone, P Roncaioli, R De Maria, G Camarda, A Santoni, G Ruberti, ...
The EMBO journal 14 (23), 5859-5868, 1995
Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic …
NKA Prasad, G Papoff, A Zeuner, E Bonnin, MD Kazatchkine, G Ruberti, ...
The Journal of Immunology 161 (7), 3781-3790, 1998
An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.
G Papoff, I Cascino, A Eramo, G Starace, DH Lynch, G Ruberti
The Journal of Immunology 156 (12), 4622-4630, 1996
Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain.
E Puré, K Inaba, MT Crowley, L Tardelli, MD Witmer-Pack, G Ruberti, ...
Journal of Experimental Medicine 172 (5), 1459-1469, 1990
Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
I Cascino, G Papoff, R De Maria, R Testi, G Ruberti
The Journal of Immunology 156 (1), 13-17, 1996
Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor
G Papoff, P Hausler, A Eramo, MG Pagano, G Di Leve, A Signore, ...
Journal of Biological Chemistry 274 (53), 38241-38250, 1999
Protection of CD95‐mediated apoptosis by activation of phosphatidylinositide 3‐kinase and protein kinase B
P Häusler, G Papoff, A Eramo, K Reif, DA Cantrell, G Ruberti
European journal of immunology 28 (1), 57-69, 1998
Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness
A Gaur, G Ruberti, R Haspel, JP Mayer, CG Fathman
Science 259 (5091), 91-94, 1993
Soluble Fas/Apo-1 splicing variants and apoptosis
I Cascino, G Papoff, A Eramo, G Ruberti
Front Biosci 1, d12-d18, 1996
The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
M Tolomeo, L Dusonchet, M Meli, S Grimaudo, N D'Alessandro, G Papoff, ...
Cell death and differentiation 5 (9), 735, 1998
Detection of polymorphisms within the FAS cDNA gene sequence by GC-clamp denaturing gradient gel eletrophoresis
G Fiucci, G Ruberti
Immunogenetics 39 (6), 437-439, 1994
The T cell receptor repertoire influences V beta element usage in response to myoglobin.
G Ruberti, A Gaur, CG Fathman, AM Livingstone
Journal of Experimental Medicine 174 (1), 83-92, 1991
Presentation of antigen by mixed isotype class II molecules in normal H-2d mice.
G Ruberti, KS Sellins, CM Hill, RN Germain, CG Fathman, A Livingstone
Journal of Experimental Medicine 175 (1), 157-162, 1992
Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells
S Varambally, Y Bar‐Dayan, J Bayry, S Lacroix‐Desmazes, M Horn, ...
International immunology 16 (3), 517-524, 2004
Fas splicing variants and their effect on apoptosis
G Ruberti, I Cascino, G Papoff, A Eramo
Mechanisms of Lymphocyte Activation and Immune Regulation VI, 125-134, 1996
Liver-derived T cell clones in autoimmune chronic active hepatitis: accessory cell function of hepatocytes expressing class II major histocompatibility complex molecules
A Franco, V Barnaba, G Ruberti, R Benvenuto, C Balsano, A Musca
Clinical immunology and immunopathology 54 (3), 382-394, 1990
CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice
A Signore, A Annovazzi, E Procaccini, PE Beales, J Spencer, R Testi, ...
Diabetologia 40 (12), 1476-1479, 1997
The 3′ UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiency
L Malquori, L Carsetti, G Ruberti
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1779 (1), 60-65, 2008
The system can't perform the operation now. Try again later.
Articles 1–20